Iranian
Biomedical Journal
Volume 30, Issue 4 (9-2026)
IBJ 2026, 30(4): 271-273 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Jalali T, Pouriayevali M H, Salehi-Vaziri M. The 2026 Bundibugyo Ebola Outbreak: A Warning for Global Preparedness for Future Epidemics. IBJ 2026; 30 (4) :271-273
URL: http://ibj.pasteur.ac.ir/article-1-5690-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5690-en.html
Abstract:
Dear Editor,
The 2026 Bundibugyo Ebolavirus (BDBV) outbreak has once again demonstrated that the threat of emerging diseases remains a major global health challenge. The outbreak, first detected in the Democratic Republic of Congo (DRC) and spread to Uganda, is not only a regional crisis but also a test of the world’s preparedness for pathogens with epidemic potential. Unlike Zaire Ebolavirus (EBOV), which has benefited from effective vaccines and treatments in recent years, BDBV still lacks a licensed vaccine or specific treatment. As of June 6, a total of 515 laboratory-confirmed cases and 91 deaths have been reported in DRC, while Uganda has reported 19 laboratory-confirmed cases and two deaths. The occurrence of unexplained deaths among both the community and healthcare workers, along with prior reports of an unidentified hemorrhagic fever, suggest that the outbreak has been likely originated in March 2026 or even earlier. Accordingly, the virus is believed to have spread unnoticed for several weeks before being identified through genomic sequencing in mid-May 2026.
The resurgence of Ebola in Africa results from a complex interaction of environmental, social, and political factors. Deforestation, the development of mining activities, the expansion of agriculture, and increased human contact with wildlife have elevated the likelihood of spillovers from wildlife reservoirs, particularly fruit bats, which are considered the most likely natural hosts of ebolaviruses. Moreover, weak disease surveillance systems and limited access to health services have delayed the identification of early cases. The similarity of the initial symptoms of Ebola to other endemic diseases in the region, such as malaria, makes early diagnosis difficult and provides ample opportunity for transmission to spread. Insecurity, misinformation, attacks on healthcare facilities, and armed conflict in the region have also posed serious challenges to the implementation of contact tracing programs and rapid response to the epidemic .....
The 2026 Bundibugyo Ebolavirus (BDBV) outbreak has once again demonstrated that the threat of emerging diseases remains a major global health challenge. The outbreak, first detected in the Democratic Republic of Congo (DRC) and spread to Uganda, is not only a regional crisis but also a test of the world’s preparedness for pathogens with epidemic potential. Unlike Zaire Ebolavirus (EBOV), which has benefited from effective vaccines and treatments in recent years, BDBV still lacks a licensed vaccine or specific treatment. As of June 6, a total of 515 laboratory-confirmed cases and 91 deaths have been reported in DRC, while Uganda has reported 19 laboratory-confirmed cases and two deaths. The occurrence of unexplained deaths among both the community and healthcare workers, along with prior reports of an unidentified hemorrhagic fever, suggest that the outbreak has been likely originated in March 2026 or even earlier. Accordingly, the virus is believed to have spread unnoticed for several weeks before being identified through genomic sequencing in mid-May 2026.
The resurgence of Ebola in Africa results from a complex interaction of environmental, social, and political factors. Deforestation, the development of mining activities, the expansion of agriculture, and increased human contact with wildlife have elevated the likelihood of spillovers from wildlife reservoirs, particularly fruit bats, which are considered the most likely natural hosts of ebolaviruses. Moreover, weak disease surveillance systems and limited access to health services have delayed the identification of early cases. The similarity of the initial symptoms of Ebola to other endemic diseases in the region, such as malaria, makes early diagnosis difficult and provides ample opportunity for transmission to spread. Insecurity, misinformation, attacks on healthcare facilities, and armed conflict in the region have also posed serious challenges to the implementation of contact tracing programs and rapid response to the epidemic .....
Type of Study: Letter to the Editor |
Subject:
Related Fields
References
1. Lupascu D, Iacob AT, Apotrosoaei M, Vasincu IM, Lupascu FG, Chirliu OM, et al. Achievements and challenges in therapy and vaccines development of viral hemorrhagic fevers: An up-to-date review. Pharmaceutics. 2026;18(4):426. [DOI:10.3390/pharmaceutics18040426]
2. Phelan AL, Nuzzo JB, Gostin LO. The PHEIC for Ebola disease caused by Bundibugyo virus: An inflection point for solidarity and health equity. Lancet. 2026;407(10545):2264-7. [DOI:10.1016/S0140-6736(26)01037-8]
3. Ohimain EI. Ecology of Ebolaviruses. Current Opinion in Pharmacology. 2021;60:66-71. [DOI:10.1016/j.coph.2021.06.009]
4. Zomahoun DL, Boyd MA, Honein MA, Montgomery JM, Zielinski-Gutierrez E, Meites E, et al. Notes from the field: Outbreak of Ebola disease caused by Bundibugyo virus-democratic republic of the Congo and Uganda, May 2026. MMWR Morb Mortal Wkly Rep. 2026;75(22):293-4. [DOI:10.15585/mmwr.mm7522e3]
5. Wamala JF, Lukwago L, Malimbo M, Nguku P, Yoti Z, Musenero M, et al. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerg Infect Dis. 2010;16(7):1087-92. [DOI:10.3201/eid1607.091525]
6. Karim SA, Mahomed S, Lewis L, Karim SSA. Urgent need for a reliable rapid diagnostic test for the Ebola epidemic caused by Bundibugyo virus in Africa. Lancet. 2026;407(10546):2346-8. [DOI:10.1016/S0140-6736(26)01093-7]
7. Kopp K. Bundibugyo virus disease: Diagnostics and medical countermeasures for a neglected Ebolavirus. 2026;18(7):775. [DOI:10.3390/v18070775]
8. Ngongo N, Fallah MP, Dereje N, Boum Y, Kaseya J. Bundibugyo Ebola without vaccines or therapeutics: Why public health fundamentals matter more than border closures. Nat Med. 2026:1-2. [DOI:10.1038/s41591-026-04482-8]
9. Iserson KV. The next pandemic: Prepare for "Disease X". West J Emerg Med. 2020;21:756-8. [DOI:10.5811/westjem.2020.5.48215]
10. Nachega JB, Muyembe-Tamfum JJ, Zumla A. Therapeutic and prophylactic strategies for Ebola caused by Bundibugyo virus. Nat Rev Drug Discov. 2026;25(7):495-6. [DOI:10.1038/d41573-026-00094-6]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |